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Abstract
Objective—To assess relationships between obstructive lung diseases, respiratory symptoms, and 
comorbidities by gender.
Methods—Data from 12 594 adult respondents to the 2012 South Carolina Behavioral Risk 
Factor Surveillance System telephone survey were used. Five categories of chronic obstructive 
airway disease (OAD) were defined: former asthma only, current asthma only, chronic obstructive 
pulmonary disease (COPD) only, asthma-COPD overlap syndrome (ACOS), and none. 
Associations of these categories with respiratory symptoms (frequent productive cough, shortness 
of breath, and impaired physical activities due to breathing problems), overall health, and 
comorbidities were assessed using multivariable logistic regression for men and women.
Results—Overall, 16.2% of men and 18.7% of women reported a physician diagnosis of COPD 
and/or asthma. Former asthma only was higher among men than women (4.9% vs. 3.2%, t-test 
p=0.008). Current asthma only was more prevalent among women than men (7.2% vs. 4.7%, 
p<0.001), as was ACOS (4.0% vs. 2.2%, p<0.001). Having COPD only did not differ between 
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women (4.3%) and men (4.4%). Adults with ACOS were most likely to report the 3 respiratory 
symptoms. COPD only and ACOS were associated with higher likelihoods of poor health and 
most comorbidities for men and women. Current asthma only was also associated with these 
outcomes among women, but not among men.
Conclusions—In this large population-based sample, women were more likely than men to 
report ACOS and current asthma, but not COPD alone. Gender differences were evident between 
the OAD groups in sociodemographic characteristics, respiratory symptoms, and comorbidities, as 
well as overall health.
Keywords
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Introduction
Chronic obstructive pulmonary disease (COPD) and lifetime asthma are diagnosed in 
approximately 6% and 13% of the US adult population, respectively [1,2]. Among adults 
with COPD, between 13% and 55% have been reported to also have asthma, termed asthma/
COPD overlap syndrome (ACOS) [3–6]. According to new guidelines, this overlap 
syndrome is characterized by persistent airflow limitation with several features of both 
asthma and COPD [7,8]. Among published studies, persons labeled with this overlap 
syndrome are reported to experience more frequent healthcare utilization and severe 
impairment than persons with COPD [3,5,6,9–12] or asthma alone [6,11,12].
Gender differences have been reported for persons with asthma, COPD, and ACOS. The 
prevalence of asthma [13] and frequency of respiratory symptoms among those with asthma 
[14,15] are higher in women than men. Although historically males were more likely than 
females to develop COPD, this began to change in the middle of the twentieth century with a 
steady increase in COPD prevalence among women [1,16]. In the past decade, more women 
than men die annually from COPD in the United States [1]. Women appear to be susceptible 
to developing COPD earlier, exhibit greater bronchial reactivity, and experience poorer 
health status than men with the same tobacco exposure [17,18]. Some, but not all, studies 
have reported ACOS to be more common in women; however, no studies have primarily 
focused on the role of gender in ACOS as compared to asthma or COPD [6,10,11,19]. The 
aim of this analysis is to describe the sociodemographic characteristics of persons with 
asthma, COPD, and ACOS and compare the frequency of respiratory symptoms, health 
impairment, and comorbidities in relationship to gender in a state’s general adult population.
Methods
Each year, state health departments collaborate with the Centers for Disease Control and 
Prevention to conduct the Behavioral Risk Factor Surveillance System (BRFSS) survey, a 
random digit-dialed telephone survey of non-institutionalized adults aged ≥18 years [20]. 
The core questionnaire with questions about chronic conditions, health behaviors, and 
sociodemographic and health characteristics is asked of all respondents, but states can also 
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add supplementary questions to their state questionnaire based on their priorities. In 2012, 
the South Carolina (SC) Department of Health and Environmental Control included a series 
of questions referred to as the COPD Risk Assessment module in collaboration with the 
North Carolina COPD Taskforce. These questions were primarily meant to identify 
respondents who might be at high risk of having COPD and included questions about 
respiratory symptoms and lifetime duration of smoking [21,22]. Response rates for BRFSS 
are calculated using standards set by the American Association of Public Opinion Research 
Response Rate Formula #4 [23]. The response rate is the number of respondents who 
completed the survey as a proportion of all eligible and likely-eligible persons. The response 
rate for SC in 2012 was 48.6%, which was higher than the median rate of 45.2% for all 50 
states and DC. For detailed information see the 2012 BRFSS Summary Data Quality Report 
[24]. As a secondary data analysis, this study was exempt from review by an institutional 
review board.
Definition of variables
Obstructive airway disease (OAD) categories—All respondents were asked, “Have 
you ever been told by a doctor, nurse, or other health professional that you have chronic 
obstructive pulmonary disease (COPD), emphysema, or chronic bronchitis?” Individuals 
who responded “yes” were defined as having COPD, while those who responded “no” or 
“don’t know” were defined as not having COPD. All respondents were also asked if they 
had ever been told they had asthma (lifetime asthma). If they responded yes to this asthma 
question, they were also asked if they still had asthma (current asthma). An affirmative 
response to the first asthma question (lifetime asthma), but a response of “no” or “don’t 
know” to the second (current asthma) was defined as former asthma. An affirmative 
response to both asthma questions was defined as current asthma. Based on these responses, 
persons were categorized into OAD categories: neither (neither asthma nor COPD), former 
asthma only (former asthma, no COPD), current asthma only (current asthma, no COPD), 
COPD only (COPD, no asthma), and ACOS (both asthma (either former or current) and 
COPD). All respondents who reported COPD were also asked whether they had ever 
undergone a breathing test to diagnose their COPD, with 78.5% reporting having had a 
diagnostic test but no information on diagnostic findings were obtained.
Respiratory symptoms—Respondents were asked, “During the past 30 days, how often 
did you feel short of breath – would you say all of the time, most of the time, some of the 
time, a little of the time, or none of the time?” We defined frequent shortness of breath 
(SOB) as a response of most of the time or all of the time. Respondents were also asked, 
“How often do you cough up mucus or phlegm?” Possible responses to this question were 
every day, most days a week, a few days a month, only with occasional colds or chest 
infections, and never. Individuals who responded either most days or every day were defined 
as having frequent productive cough. Finally, respondents were asked, “Thinking about your 
physical activity during the last 12 months, do you agree slightly or strongly or disagree 
slightly or strongly with the following statement: I do less now than I used to because of my 
breathing problems.” Possible responses included agree strongly, agree slightly, neither 
agree or disagree, disagree slightly, and disagree strongly. If respondents agreed strongly or 
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slightly, they were characterized as agreeing that breathing problems limited their physical 
activity.
Non-respiratory chronic conditions and overall health—In addition to asthma and 
COPD, respondents were also asked whether they had been told by a healthcare professional 
that they had angina or coronary heart disease; diabetes; arthritis, rheumatoid arthritis, gout, 
lupus, or fibromyalgia; cancer (other than skin cancer); a depressive disorder, including 
depression, major depression, dysthymia, or minor depression; or a stroke. Respondents 
were also asked to rate their health as excellent, very good, good, fair, or poor. Frequent 
mental distress was defined as a response of ≥14 days to the question, “Now thinking about 
your mental health, which includes stress, depression, and problems with emotions, for how 
many days during the past 30 days was your mental health not good.” Frequent physical 
distress was defined as a response of ≥14 days to the question, “Now thinking about your 
physical health, which includes physical illness and injury, for how many days during the 
past 30 days was your physical health not good.”
Smoking status—All respondents were asked, “Have you smoked at least 100 cigarettes 
in your entire life?” Persons who responded “no” were categorized as never smokers. 
Persons who responded “yes” were further asked, “Do you now smoke cigarettes every day, 
some days, or not at all?” Persons who responded “not at all” were defined as former 
smokers with the remainder defined as current smokers. Current and former smokers were 
also asked, “Over your lifetime, how many years have you smoked tobacco products?” 
Smoking duration for this study was defined as smoked ≥10 years, smoked <10 years or 
unknown duration, and never smoked.
Other respondent characteristics—Socio-demographic characteristics included 
gender, age, race (white, black, or other/multiracial), and education (less than high school 
diploma; high school graduate or general equivalency diploma; or at least some college). 
Survey respondents’ body mass index (BMI) was calculated from their self-reported weight 
and height (weight [kg]/height [m2]) and used to categorize respondents as underweight 
(BMI <18.5 kg/m2), normal weight (BMI = 18.5–24.9 kg/m2), overweight (BMI = 25.0–
29.9 kg/m2), and obese (BMI = ≥30.0 kg/m2).
Exclusions—In 2012, 12 795 SC adults were surveyed. Respondents were excluded if they 
were missing data on age (n=105), race (n=94), or COPD (n=2) (total excluded=201). The 
final sample size for data analysis included 12 594 adults (94% of adults).
Statistical analysis
All analyses were gender-specific and were conducted using SAS-callable SUDAAN 
(Release 11.0.0, Research Triangle Institute, NC) to account for the complex sampling 
design. First we examined the distribution of selected characteristics among study 
respondents. Then we assessed the unadjusted prevalence and 95% confidence interval (CI) 
of OADs for the total population and by age groups. We also assessed the age-adjusted 
prevalence of each OAD group by sociodemographic and other selected characteristics. T-
tests were used to assess differences in prevalence between subgroups. We then examined 
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the association between OAD group and smoking status, smoking ≥10 years, being obese, 
and having each of the three respiratory symptoms. Using the ADJRR option on the 
PREDMARG statement in PROC RLOGIST, we assessed adjusted prevalences, prevalence 
ratios (PR), and 95% CI in models that adjusted for age, race, and education. The models for 
the respiratory symptoms also included smoking status and BMI category. In addition, 
PRED_EFF statements were used to conduct t-tests for model-adjusted prevalence 
differences between non-referent categories. Finally, we also assessed prevalence, PRs, and 
95% CI for individual chronic diseases, ≥1 non-respiratory chronic disease, and physical and 
mental impairments by OAD group in separate multivariable logistic regression analyses 
that adjusted for age, race, education, BMI category, and smoking status. Statistical 
significance was defined at the p<0.05 level.
Results
Compared with the men, women were slightly older and had higher percentages of black 
respondents and respondents with at least some college education. Women were more likely 
than men to have never smoked; to have a normal BMI or be obese; to report fair/poor 
health, frequent mental distress, and frequent physical distress; and to report having arthritis, 
cancer, depression, as well as at least one non-respiratory chronic condition. Women were 
also more likely than men to report frequent SOB. Men, on the other hand, were more likely 
than women to have smoked ≥10 years, be overweight, and have coronary heart disease. 
Overall, 16.2% of men and 18.7% of women reported a physician diagnosis of COPD and/or 
asthma. Former asthma only was higher among men than women (4.9% vs. 3.2%, p=0.008). 
Current asthma only was more prevalent among women than men (7.2% vs. 4.7%, p<0.001), 
as was ACOS (4.0% vs. 2.2%, p<0.001). Having COPD only did not differ between women 
(4.3%) and men (4.4%) (Table 1). Among respondents with COPD and/or asthma, 13.9% of 
men and 21.2% of women had ACOS.
Women had a higher age-adjusted prevalence of any asthma (former asthma only, current 
asthma only, or ACOS; 14.5% vs. 12.0%, p=0.013) and any COPD (COPD only or ACOS; 
7.6% vs. 6.3%, p=0.050) than men. Men had a higher age-adjusted prevalence of former 
asthma only (5.1% vs. 3.3%, p=0.008), but women had a higher age-adjusted prevalence of 
current asthma only (7.4% vs 4.8%, p<0.001) and ACOS (3.8% vs 2.1%, p<0.001). The age-
adjusted prevalence of COPD only did not differ between men and women (4.2% vs 3.9%, 
p=0.508). Increasing age was associated with lower prevalence of former asthma only and 
current asthma only and higher prevalence of COPD only and ACOS for both men and 
women (all linear trends p<0.05). Among men, black respondents reported current asthma 
only more than white respondents (7.4% vs 3.7%, p=0.003). Among women however, there 
were no differences in any OAD prevalence between black and white respondents. Among 
both men and women, respondents with less than a high school education had a higher 
prevalence of current asthma only, COPD only, and ACOS than respondents with at least 
some college education (p<0.05 for each comparison). Among both men and women, 
prevalence of COPD only was highest for current smokers and lowest for never smokers 
(men: 8.8% vs 1.8%, p<0.001; women: 10.4% vs 1.8%, p<0.001). ACOS prevalence was 
highest for current smokers and lowest for never smokers among women (7.5% vs 2.1%, 
p<0.001), but did not vary significantly by smoking status among men. Among men, the 
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prevalence of COPD only was higher for those who reported smoking ≥10 years (7.6%) than 
for never smokers (1.8%, p<0.001) or those who smoked <10 years (2.9%, p<0.001), with 
no statistically significant difference between never smokers and those who smoked <10 
years. Among women, the prevalence of COPD only was higher for women who smoked 
<10 years compared with never smokers (4.6% vs 1.8%, p=0.002) and higher still for 
women who smoked ≥10 years (8.2% vs 4.6%, p=0.027). The prevalence of ACOS, 
however, was only significantly higher for women who smoked ≥10 years (8.1% vs 3.7% for 
those who smoked <10 years [p=0.002] and 2.1% for never smokers [p<0.001]). Among 
men, prevalence of current asthma only, COPD only, and ACOS varied by BMI. Men who 
were obese were more likely to have current asthma only and ACOS compared to men in the 
normal weight or overweight categories; however, numbers of underweight men were 
relatively small. The prevalence of COPD only was lower among overweight men compared 
with men who were normal weight (3.0% vs 5.7%, p=0.009). Among women, BMI was only 
associated with ACOS prevalence, with women who were obese having a higher prevalence 
(5.9%) than women who were normal weight (2.1%, p<0.001) or overweight (3.0%, 
p=0.001) (Table 2).
Among men, the likelihood of current smoking was higher for those with COPD only 
(PR=2.1 [95% CI: 1.7–2.5]), but not those with ACOS, compared to men with no OAD. 
Women with COPD only (PR=2.4 [95% CI: 1.9–3.0] or ACOS (PR=2.0 [95% CI: 1.6–2.6]) 
were more likely to be current smokers than women with no OAD. Likelihood of former 
smoking did not vary by OAD category among men, but was higher among women with 
ACOS compared to those with no OAD (PR=1.2 [95% CI: 1.001–1.6]). Among both men 
and women, the likelihood of having smoked ≥10 years was higher for those who had COPD 
only (men: PR=1.8 [95% CI: 1.6–2.1]; women: PR=2.1 [95% CI: 1.8–2.5]) or ACOS (men: 
PR=1.6 [95% CI: 1.3–2.1]; women: PR=2.1 [95% CI: 1.7–2.5]) compared to those with no 
OAD. Among both men and women, the likelihood of obesity was higher for groups with 
current asthma only (men: PR=1.7 [95% CI: 1.4–2.1]; women: PR=1.2 [95% CI: 1.03–1.5]) 
or ACOS (men: PR=1.7 [95% CI: 1.3–2.3]; women: PR=1.6 [95% CI: 1.4–1.9]), but not 
former asthma only or COPD only, compared to the no OAD group. Among men, the 
likelihood of each respiratory symptom was higher for those in the COPD only (frequent 
productive cough: PR=3.5 [95% CI: 2.5–4.7]; frequent SOB: PR=6.4 [95% CI: 4.1–10.1]; 
limited physical activity: PR=3.5 [95% CI: 2.7–4.4]) and ACOS groups (frequent productive 
cough: PR=3.8 [95% CI: 2.7–5.5]; frequent SOB: PR=14.2 [95% CI: 9.2–22.1]; limited 
physical activity: PR=6.1 [95% CI: 4.6–8.1]) compared with those with no OAD. The 
difference was especially notable for frequent SOB. In addition, the likelihood of limited 
activity due to breathing problems was higher for those with current asthma only compared 
to those with no airway disease (PR=1.8 [95% CI: 1.2–2.8]). However, neither frequent 
productive cough nor frequent SOB was elevated for this group. The adjusted prevalence of 
each respiratory symptom was also higher for those with ACOS compared with current 
asthma alone (frequent productive cough: 34.9% vs 10.2%, p<0.001; frequent SOB: 29.2% 
vs 2.5%, p<0.001; limited physical activity: 67.1% vs 20.0%, p<0.001). Compared to the 
COPD alone group, the prevalence of frequent SOB (29.2% vs 13.2%, p=0.002) and limited 
physical activity (67.1% vs 38.0%, p=0.001) was higher for those with ACOS. Among 
women, the likelihood of each respiratory symptom was higher in the current asthma only 
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(frequent productive cough: PR=2.9 [95% CI: 2.1–4.0]; frequent SOB: PR=6.0 [95% CI: 
3.7–9.6]; limited physical activity: PR=3.7 [95% CI: 3.0–4.7]), COPD only (frequent 
productive cough: PR=3.9 [95% CI: 2.9–5.1]; frequent SOB: PR=4.7 [95% CI: 3.0–7.5]; 
limited physical activity: PR=4.0 [95% CI: 3.1–5.2]), and ACOS groups (frequent 
productive cough: PR=6.2 [95% CI: 4.8–8.0]; frequent SOB: PR=11.3 [95% CI: 7.6–16.9]; 
limited physical activity: PR=6.0 [95% CI: 5.0–7.2]) compared with the group with no 
airway disease. The adjusted prevalence of each respiratory symptom was also higher for 
those with ACOS compared with either current asthma alone (frequent productive cough: 
38.0% vs 17.7%, p<0.001; frequent SOB: 26.9% vs 14.2%, p=0.005; limited physical 
activity: 55.9% vs 34.7%, p<0.001) or COPD alone (frequent productive cough: 38.0% vs 
23.9%, p=0.003; frequent SOB: 26.9% vs 11.3%, p<0.001; limited physical activity: 55.9% 
vs 37.6%, p=0.002). As among the men, the association with airway disease was strongest 
for frequent SOB (Table 3).
Among men, current asthma only was not associated with increased likelihood of poor 
overall health or any chronic health condition compared with the group with neither airway 
disease. However, former asthma only was associated with a higher likelihood of diabetes 
(PR=1.5 [95% CI: 1.01–2.2]) and depression (PR=1.9 [95% CI: 1.2–3.0]). Men with COPD 
only had a higher likelihood of the three poor overall health measures (fair/poor health: 
PR=2.2 [95% CI: 1.7–2.8]; frequent mental distress: PR=2.3 [95% CI: 1.6–3.4]; frequent 
physical distress: PR=2.5 [95% CI: 1.8–3.3]) as well as coronary heart disease (CHD) 
(PR=2.8 [95% CI: 2.0–4.1]), arthritis (PR=1.7 [95% CI: 1.4–2.2]), cancer (PR=1.7 [95% CI: 
1.2–2.6]), and depression (PR=2.2 [95% CI: 1.6–3.1]). Men with ACOS had a higher 
likelihood of the three poor overall health measures (fair/poor health: PR=3.3 [95% CI: 2.6–
4.2]; frequent mental distress: PR=2.9 [95% CI: 1.9–4.5]; frequent physical distress: PR=4.7 
[95% CI: 3.5–6.2]) and all chronic health conditions except cancer (PR ranged from 1.8 for 
diabetes to 3.4 for depression) compared with the group with no airway disease. In addition, 
compared to men with COPD only, men with ACOS reported a higher prevalence of fair/
poor health (52.7% vs 34.5%, p=0.008), frequent physical distress (46.5% vs 24.6%, 
p=0.001), and at least one non-respiratory chronic disease (74.0% vs 55.7%, p=0.024). 
Among women, the current asthma only, COPD only, and ACOS groups had higher 
likelihoods of the three poor overall health measures compared to women with no OAD. 
Compared to women with no OAD, women with former asthma had a higher likelihood of 
cancer (PR=1.8 [95% CI: 1.03–3.1]) and depression (PR=1.6 [95% CI: 1.2–2.1], but not of 
any of the poor overall health measures or other chronic health conditions. Women with 
current asthma only or COPD only had higher likelihood of all of the chronic health 
conditions except cancer, while those with ACOS had a higher likelihood of all of the 
chronic health conditions. Additionally, compared to women with current asthma only, those 
with ACOS had a higher prevalence of fair/poor health (48.4% vs 31.5%, p=0.001), frequent 
mental distress (28.6% vs 18.7%, p=0.033), frequent physical distress (34.9% vs 23.6%, 
p=0.019), cancer (18.2% vs 8.1%, p=0.001), depression (41.3% vs 28.3%, p=0.010), and at 
least one non-respiratory chronic disease (76.3% vs 60.6%, p=0.004). The PRs for ACOS 
were generally similar to those for COPD only; however, the adjusted prevalence of cancer 
was higher among women with ACOS compared to those with COPD only (18.2% vs 
10.4%, p=0.009) (Table 4).
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We undertook an analysis of a state’s health survey (2012 SC BRFSS) in more than 10,000 
adults that included questions about socio-demographics, health behaviors, respiratory 
symptoms, major chronic diseases, and health impairment. Although the unadjusted 
prevalence of ACOS was low (2.2% in men and 4.0% in women) among adults in South 
Carolina, ACOS was reported by one of every six adults (13.9% in men and 21.2% in 
women) who had either COPD or asthma. Gender differences were evident between the four 
OAD groups in disease prevalence, socio-demographic characteristics, smoking history, and 
comorbidities as well as health status and impairment.
In our study, the prevalence of current asthma only (4.7% of men and 7.2% of women), 
COPD only (4.4% of men and 4.3% of women), and ACOS (2.2% of men and 4.0% of 
women) are consistent with most other studies. Among two US, one Asian, one Latin 
American, and two European cross-sectional studies, the prevalence of asthma only, COPD 
only, and ACOS ranged from 1.7–6.2%, 3.1–11.7%, and 1.8–2.7%, respectively 
[3,5,6,12,19]. This and other studies show that women are more likely than men to have 
ACOS [3,6,12,25]. In prevalence studies that did not evaluate ACOS, women were more 
likely than men to have current asthma [13] and COPD [1]. In our study, women were also 
more likely than men to report any asthma (represented in either asthma only group and the 
ACOS group) and COPD (represented in the COPD only and ACOS groups). An Italian 
study that included an ACOS group [6] reported that prevalence of ever asthma or COPD 
was not significantly different by gender, whereas the PLATINO study reported that 75% of 
the asthma only group was female [5]. Some studies reporting characteristics of patients 
with ACOS show a younger mean age compared to those with COPD alone [10,12,25], 
whereas others did not [3,26]. In the current study, women with ACOS were younger than 
those with COPD only (mean age 52.8 years vs. 58.4 years, p<0.01), although there was no 
significant age difference for men. The prevalence of asthma and COPD, and likely other 
characteristics of these patient types, may be affected by whether individuals with ACOS are 
considered a separate group.
Why some patients with asthma or COPD go on to develop ACOS may be related to unique 
immunological responses, genetic predisposition, or other factors. Adults with asthma, even 
after adjusting for smoking history, are at a 12-fold higher risk of developing COPD than 
those without asthma [27]. This finding may explain why the prevalence of ACOS in our 
study was higher among women, who are also more likely to have asthma. A recent study 
evaluated whether expression of asthma-associated gene signatures (T helper type 2) were 
increased in COPD patients and found that higher scores were associated with worse lung 
function and more “asthma-like” features, but not with asthma history [28]. In a group of 
3500 subjects who were part of the Genetic Epidemiology of COPD (COPDGene) study, 
several genetic variants associated with ACOS approached genome-wide significance, 
although the authors hypothesized that the study was underpowered for that portion of their 
analysis [10].
Prior studies have indicated that women are more susceptible than men to the effects of 
tobacco smoking [29–31]. In our study, men who smoked <10 years did not have a higher 
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prevalence of COPD only or ACOS than never smokers. However, compared to never 
smokers, women who smoked <10 years had a higher prevalence of COPD only, with an 
even higher prevalence for those who smoked ≥10 years. Of note, the prevalence of ACOS 
among those who smoked ≥10 years was more than double for women compared to men. 
When limiting our analyses to never smokers only, men and women had a similar prevalence 
of COPD only and ACOS.
A number of studies support that obesity and weight gain are a major risk factor for declines 
in lung function [32–34], respiratory symptoms [35,36], asthma [37], and COPD [35], 
although some studies have observed a lower risk for COPD, especially emphysema, with 
obesity [38,39]. In the current study, obesity was more common in the current asthma only 
and ACOS groups. With respect to gender, three studies observed that the association 
between FEV1 decline and obesity or weight gain were stronger for men than women [32–
34]. Guerra et al. however observed an association between excess weight and asthma 
among women only [37]. We noted a slightly stronger association between obesity and 
current asthma only for men than women, but similar associations for the ACOS group.
Prior to our study, no other publication has described the frequency and type of respiratory 
symptoms in relationship to gender in a population that distinguished asthma, COPD, and 
ACOS. In our study, the most common respiratory symptom reported was limitation of 
physical activity due to breathing problems, followed by frequent productive cough, and 
then frequent SOB; the latter was reported more commonly by women. In other general 
adult population studies, women reported respiratory symptoms more often than men 
[40,41]. We observed that both men and women with COPD only were more likely than 
those without OAD to report respiratory symptoms, while the risk was even higher for those 
with ACOS. Current asthma only was associated with frequent productive cough and 
frequent SOB among women, but not among men. Although frequent SOB was not reported 
as often as the other respiratory symptoms among the respondents in our study, frequent 
SOB was very evident in ACOS (PR > 11) and COPD (PR > 4) compared to no OAD. Other 
groups have also shown greater risk of respiratory symptoms in ACOS than COPD [5,6] and 
asthma [6,42].
Other studies have reported that health impairment is more frequent and severe in patients 
with ACOS compared to other OAD [3,19,26]. We found that OADs increased the likelihood 
of poor health status and frequent mental and physical distress, but with some differences by 
gender. Among men, although the likelihood of each of these measures was significantly 
higher for the COPD only and ACOS groups than the no OAD group, only the likelihood of 
frequent physical distress was significantly higher for those with ACOS compared to COPD 
only. Among women, the likelihood of these three measures was higher for the current 
asthma only, COPD only, and ACOS groups compared to the no OAD group, but the 
likelihood of fair/poor health and frequent physical distress was comparable for the ACOS 
and COPD only groups.
Comorbidities have been reported to be more common in ACOS than COPD [19,25] and 
asthma [11,19]. It is known that COPD alone increases the risk of comorbidities [43,44]. We 
found that most non-respiratory comorbidities were more common in the COPD only and 
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ACOS groups than in persons with no OAD among both men and women. However in 
general, we found that the current asthma only group was similar to the no OAD group 
among men, but more similar to the COPD only and ACOS groups among women. Both 
men and women with ACOS or COPD only in our study reported higher rates of coronary 
heart disease compared to respondents with no OAD. An increased risk of coronary heart 
disease in COPD has been previously reported [45]. Systemic effects of airway 
inflammation may play a role in some non-pulmonary diseases such as coronary artery 
disease [45,46]. Compared to respondents with no OAD, men with COPD only and women 
with former asthma only or ACOS had a higher likelihood of cancer. In the only other study 
of ACOS reporting cancer history, there was no difference in rates of cancer between ACOS 
and COPD [25]. Due to the low prevalence of cancer in our sample and therefore unreliable 
estimates, we were not able to compare cancer prevalence in the COPD only and ACOS 
groups.
This study was subject to some limitations. First, this was a cross-sectional study; therefore 
we could not confirm causality in the relationships between OAD and the other variables in 
the study. Second, all the information on OAD and other chronic condition diagnoses was 
self-reported. There is evidence that similar questions asking about physician diagnoses of 
COPD, emphysema, and chronic bronchitis have high specificity and low sensitivity [47], 
which would result in misclassification of individuals with COPD as not having COPD. This 
would tend to bias estimates towards the null. Third, the study population is representative of 
non-institutionalized adults in South Carolina. Therefore, individuals with more severe 
OADs and other chronic conditions may reside in facilities that are not included in the 
survey.
Conclusion
Although there may never be a clear distinction between asthma, COPD, and ACOS in all 
patients, it is imperative to undertake research to better understand the phenotypic and 
genotypic characteristics of this population as well as the most effective interventions to 
minimize impact. In this study of more than 10 000 adults in South Carolina, ACOS was an 
important phenotype of OAD and compared to asthma or COPD alone sometimes exhibited 
the most substantial health impairment, respiratory symptoms, and a higher frequency of 
comorbidities. Gender differences were evident regarding the prevalence of the OAD groups, 
sociodemographic characteristics, smoking history, and comorbidities as well as health 
status and impairment. The principal difference was in the association of current asthma 
only with respiratory symptoms and comorbidities, with this group being more comparable 
to the no OAD group among men but with the COPD only and ACOS groups among 
women. Inclusion of an ACOS group has a significant impact on the reported characteristics 
of persons with asthma or COPD alone. This study provides useful information about the 
prevalence, patient characteristics, and respiratory symptoms in persons with asthma and/or 
COPD in relationship to gender in a US state’s adult population. This type of data may assist 
in methodologies for clinical and population health research. Clearly, it is necessary to 
continue to re-evaluate the view of COPD and asthma as distinct diseases, and to consider 
circumstances where characteristics of both exist in the same patient, such as an asthmatic 
with significant smoking history or prolonged, excessive bronchial hyper-reactivity [48].
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